Skip to main content
Explore URMC

URMC Logo

menu

Russell Hilf, Ph.D.

Contact Information

Phone Numbers

Office: (585) 275-3085

Fax: (585) 275-6007

Biography

Research

Hormone action is mediated by specific cell receptors, resulting in a variety of metabolic responses and/or growth. A number of hormones are implicated in the etiology and growth of mammary cancer. Our studies are directed towards elucidation of the roles of estrogens and antiestrogens, insulin and insulin-like growth factors (IGFS) as regulators of neoplastic growth. By utilizing well characterized rodent models, in vivo and in vitro, experiments are designed to gain understanding of these regulatory actions.

Mechanism of action of estrogens and antiestrogens is being studied by defining the nucleotide requirements for binding of estrogen and antiestrogen activated estrogen receptor with their DNA regulatory element (ERE) and by transfection assays. Estrogen response depends on the expression level of one or both estrogen receptor (ER) isoforms, alpha and beta, and the concentration and type of ER-ligands. Our goal is to understand how these factors contribute to the level of induction characteristic of a particular gene. We have now established that insulin affects tumor growth and regulation, both directly and in a permissive role. We have examined insulin and estrogen receptors, how they are regulated by hormones and how such regulation relates to changes in tumor growth behavior.

A second active area of study is to define the mechanisms whereby tumor cytotoxicity ensues photoradiation therapy, a treatment approach that employs hematoporphyrin photosensitizers followed by exposure of tumors to visible light. The singlet oxygen produced is cytotoxic. We reported that important cellular targets are several mitochondrial respiratory enzymes, leading to reduced ATP production. Current aims are to elucidate these actions and to evolve methods to optimize therapeutic efficacy. The role of estrogenic and antiestrogenic agents in altering production of protoporphyrin IX from 5-aminolevulinic acid and the actions of new synthetic prophyrin derivatives are ongoing projects aimed at improving PDT outcome.

Credentials

Faculty Appointments

Education

1952
BS | Cuny City College
Chemistry

1955
PhD | Rutgers State University
Biochemistry

1953
MS | Rutgers State University
Biochemistry

Publications

Journal Articles

3/2016
Bertozzi C, Zimmermann I, Engeler S, Hilf RJ, Dutzler R. "Signal Transduction at the Domain Interface of Prokaryotic Pentameric Ligand-Gated Ion Channels." PLoS biology.. 2016 Mar 0; 14(3):e1002393. Epub 2016 Mar 04.

11/2010
Hilf RJ, Bertozzi C, Zimmermann I, Reiter A, Trauner D, Dutzler R. "Structural basis of open channel block in a prokaryotic pentameric ligand-gated ion channel." Nature structural & molecular biology.. 2010 Nov 0; 17(11):1330-6. Epub 2010 Oct 31.

8/2009
Hilf RJ, Dutzler R. "A prokaryotic perspective on pentameric ligand-gated ion channel structure." Current opinion in structural biology.. 2009 Aug 0; 19(4):418-24. Epub 2009 Jul 29.

VIEW ALL PUBLICATIONS